☆NEA Management Company, LLC
Quality Q
0.748
AUM ($M)
1,588
Positions
26
Turnover
0.25
Top-10 wt
90%
Herfindahl
0.097
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 27 positions · portfolio value $1,588M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆TRVI funds › | Trevi Therapeutics, Inc. | HOLD | — | 15.5% | +6.6% | 246.6 | 13,222,228 | +0 | 5 | — |
| ☆MBX funds › | MBX Biosciences, Inc. | HOLD | — | 12.6% | +6.4% | 199.5 | 3,614,486 | +0 | 5 | — |
| ☆GLUE funds › | Monte Rosa Therapeutics, Inc. | HOLD | — | 11.7% | +4.5% | 186.2 | 7,692,298 | +0 | 5 | — |
| ☆CELC funds › | Celcuity Inc. | TRIM | — | 11.3% | -3.6% | 179.0 | 1,710,561 | -575,000 | 5 | — |
| ☆SGP funds › | Spyglass Pharma, Inc. | HOLD | — | 10.4% | -0.5% | 164.6 | 7,392,301 | +0 | 2 | — |
| ☆SVRA funds › | Savara, Inc. | HOLD | — | 9.5% | +1.9% | 150.7 | 24,471,264 | +0 | 5 | — |
| ☆ZBIO funds › | Zenas BioPharma, Inc. | HOLD | — | 6.4% | +2.0% | 102.1 | 4,023,219 | +0 | 5 | — |
| ☆COUR funds › | Coursera, Inc. | HOLD | — | 4.6% | +0.3% | 72.6 | 12,867,769 | +0 | 5 | — |
| ☆AUPH funds › | Aurinia Pharmaceuticals, Inc. | HOLD | — | 4.2% | +0.9% | 67.4 | 3,969,834 | +0 | 5 | — |
| ☆CRSP funds › | CRISPR Therapeutics AG | HOLD | — | 3.6% | +0.8% | 57.7 | 1,058,570 | +0 | 5 | — |
| ☆ORIC funds › | ORIC Pharmaceuticals, Inc. | HOLD | — | 2.8% | -0.2% | 44.6 | 4,118,621 | +0 | 5 | — |
| ☆PHAT funds › | Phathom Pharmaceuticals, Inc. | HOLD | — | 1.3% | +0.1% | 21.3 | 1,960,169 | +0 | 5 | — |
| ☆KRRO funds › | Korro Bio, Inc. | HOLD | — | 1.1% | +0.2% | 17.1 | 1,297,893 | +0 | 5 | — |
| ☆CUSIP:98420X103 funds › | X4 Pharmaceuticals, Inc. | HOLD | — | 1.0% | +0.2% | 15.1 | 3,233,743 | +0 | 5 | — |
| ☆CSBR funds › | Champions Oncology, Inc. | HOLD | — | 0.7% | +0.1% | 10.6 | 1,713,720 | +0 | 5 | — |
| ☆CUSIP:65487U108 funds › | Nkarta, Inc. | HOLD | — | 0.6% | +0.2% | 10.1 | 3,568,781 | +0 | 5 | — |
| ☆CVRX funds › | CVRx, Inc. | TRIM | — | 0.6% | -0.5% | 10.0 | 1,954,440 | -71,643 | 5 | — |
| ☆BDTX funds › | Black Diamond Therapeutics, Inc. | HOLD | — | 0.5% | -0.0% | 8.2 | 4,448,757 | +0 | 5 | — |
| ☆KPTI funds › | Karyopharm Therapeutics Inc. | NEW | — | 0.4% | +0.4% | 5.6 | 576,780 | +576,780 | 1 | — |
| ☆IVA funds › | Inventiva SA | HOLD | — | 0.3% | -0.1% | 5.5 | 1,462,586 | +0 | 5 | — |
| ☆LONA funds › | LeonaBio, Inc. | HOLD | — | 0.3% | -0.0% | 4.3 | 464,398 | +0 | 3 | — |
| ☆CUSIP:81726A209 funds › | Senti Biosciences, Inc. | HOLD | — | 0.3% | +0.1% | 4.2 | 3,775,615 | +0 | 5 | — |
| ☆MRKR funds › | Marker Therapeutics, Inc. | HOLD | — | 0.2% | +0.0% | 2.4 | 1,625,678 | +0 | 5 | — |
| ☆OKUR funds › | OnKure Therapeutics, Inc. | HOLD | — | 0.1% | +0.0% | 2.2 | 478,548 | +0 | 5 | — |
| ☆IMA funds › | ImageneBio, Inc. | HOLD | — | 0.0% | +0.0% | 0.3 | 50,005 | +0 | 4 | — |
| ☆GOSS funds › | Gossamer Bio, Inc. | HOLD | — | 0.0% | -0.0% | 0.2 | 1,000,000 | +0 | 5 | — |
| ☆CUSIP:03940C100 funds › | Arcellx, Inc. | EXIT | — | 0.0% | -19.9% | 0.0 | 0 | -3,045,262 | 0 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 1,588 | 26 | 0.25 | 90% | 0.097 | 0.746 | — | in |
| 2026Q1 | 1,759 | 26 | 0.25 | 88% | 0.103 | 0.751 | — | in |
| 2025Q4 | 1,961 | 27 | 0.27 | 86% | 0.098 | 0.673 | — | in |
| 2025Q3 | 1,822 | 29 | 0.13 | 79% | 0.087 | 0.830 | — | in |
| 2025Q2 | 1,328 | 32 | 0.16 | 81% | 0.100 | 0.808 | — | entered |
| 2025Q1 | 1,298 | 38 | 0.00 | 80% | 0.092 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status